Il-6, Il-1β and cytokine-targeted therapy for COVID -19 patients: two more reasons to take into account statins?
- PMID: 35323082
- PMCID: PMC9115788
- DOI: 10.1080/14779072.2022.2058490
Il-6, Il-1β and cytokine-targeted therapy for COVID -19 patients: two more reasons to take into account statins?
Keywords: ARDS; COVID-19; IL-1β; IL-6; statins.
Figures
References
-
- Kashour T, Halwani R, Arabi YM, et al. Statins as an adjunctive therapy for COVID-19: the biological and clinical plausibility. Immunopharmacol Immunotoxicol. 2021;43(1):37–50. - PubMed
-
- Gupta A, Madhavan MV, Poterucha TJ, et al. Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19. Nat Commun. Res Sq [Preprint]. 2020. Aug 11:rs.3.rs-56210;12(1):1325. DOI: 10.21203/rs.3.rs-56210/v1. PMID: 32818209; PMCID: PMC7430584.2021. - DOI - PMC - PubMed
-
- Daniels LB, Ren J, Kumar K, et al. Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: findings from the American Heart Association’s COVID-19 cardiovascular disease registry. PLoS One. 2021;16(7):e0254635. - PMC - PubMed
-
•• This is an interesting paper about the effects of statin administration on SARS-CoV2 infection.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical